Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Cash & Equivalents: 2010-2024

Historic Cash & Equivalents for Alkermes (ALKS) over the last 15 years, with Dec 2024 value amounting to $291.1 million.

  • Alkermes' Cash & Equivalents rose 55.55% to $616.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $616.4 million, marking a year-over-year increase of 55.55%. This contributed to the annual value of $291.1 million for FY2024, which is 36.36% down from last year.
  • As of FY2024, Alkermes' Cash & Equivalents stood at $291.1 million, which was down 36.36% from $457.5 million recorded in FY2023.
  • In the past 5 years, Alkermes' Cash & Equivalents registered a high of $457.5 million during FY2023, and its lowest value of $273.0 million during FY2020.
  • Moreover, its 3-year median value for Cash & Equivalents was $292.5 million (2022), whereas its average is $347.0 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first spiked by 56.41% in 2023, then slumped by 36.36% in 2024.
  • Alkermes' Cash & Equivalents (Yearly) stood at $273.0 million in 2020, then grew by 23.66% to $337.5 million in 2021, then declined by 13.35% to $292.5 million in 2022, then spiked by 56.41% to $457.5 million in 2023, then plummeted by 36.36% to $291.1 million in 2024.